News Source: Uinta County News
| 2 months ago
Semafore Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics targeting the phosphoinositide-3-kinase (PI3K) pathway for the treatment of cancer and other...
News Source: The Noblesville Ledger
| 2 months ago
Becker, will serve as acting chief executive officer of Semafore, which continues to specialize on a compound, the PI3 kinase inhibitor, which interferes with communication between cancer cells and a patient's body. Clinical trials in humans began in...